Alzheimer’s disease drug development pipeline: 2021

Cummings, Jeffrey, Lee, Garam, Zhong, Kate, Fonseca, Jorge, Taghva, Kazem·2021·Alzheimer's & Dementia: Translational Research & Clinical Interventions

Cited by (535)

Items 401–500 of 535

  1. The biological diagnosis of Alzheimer’s disease using blood-based biomarkers: A Canadian prospective
    Pankaj Kumar, Ali Mousavi, Hans Frykman · 2025 · Clinical Biochemistry
  2. High content screening miniaturization and single cell imaging of mature human feeder layer-free iPSC-derived neurons
    Elizabeth R. Sharlow, Danielle C. Llaneza, William E. Grever, Garnett A. Mingledorff, Anna J. Mendelson, George S. Bloom, John Stephen Lazo · 2022 · SLAS DISCOVERY
  3. Alzheimer’s Disease: An Insightful Review on the Future Trends of the Effective Therapeutics
    Afreen Hashmi, Vivek Srivastava, Syed Abul Kalam, Devesh Kumar Mishra · 2022 · IntechOpen eBooks
  4. A protein aggregation platform that distinguishes oligomers from amyloid fibrils
    Amy Zhang, Diana Portugal Barron, Erica W. Chen, Zhefeng Guo · 2023 · The Analyst
  5. Neurodegenerative Diseases: from the First CNS Drugs to New Treatments in Discovery (A Review)
    Jean‐Louis Kraus · 2024 · Russian Journal of Bioorganic Chemistry
  6. Phototherapy with physically and molecularly produced light for Alzheimer’s disease
    Shi Kuang, Biyue Zhu, Jing Zhang, Fan Yang, Bo Wu, Weihua Ding, Shiqian Shen, Can Martin Zhang, Chongzhao Ran · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  7. A single-cell atlas of the human brain in Alzheimer’s disease and its implications for personalized drug repositioning
    Guangsheng Pei, Brisa Simões Fernandes, Yin‐Ying Wang, Astrid Marilyn Manuel, Peilin Jia, Zhongming Zhao · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  8. Stealth liposomes encapsulating a potent ACAT1/SOAT1 inhibitor F12511: pharmacokinetic, biodistribution and toxicity studies in wild-type mice, and efficacy studies in triple transgenic Alzheimer Disease mice
    Adrianna L. De La Torre, Thao Nguyen Thanh Huynh, Catherine C.Y. Chang, Darcy B. Pooler, Dylan B. Ness, Lionel D. Lewis, Sanjana Pannem, Yichen Feng, Kimberley S. Samkoe, William F. Hickey et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  9. Anosognosia for Memory Deficits in Mild Cognitive Impairment: “My Memory Runs as Usual”
    Ciro Rosario Ilardi · 2024 · Springer eBooks
  10. Baseline serum glutamate: Implications for diagnosis and prediction in mild cognitive impairment and Alzheimer’s disease of the Alzheimer’s Disease Neuroimaging Initiative
    Ying Gao, Hua Zhang, Yuming Hu · 2024 · Journal of Clinical Neuroscience
  11. The complex interplay between ligand strain, coulombic interactions, and binding site dynamics of two congeneric AChE inhibitors
    Aravinda Babu, Chandran Remya, Ayyiliath Meleveetil Sajith, Kalarickal Vijayan Dileep, Sunil Kenchaiah., Ajit Khade, Grigory V. Zyryanov, Muthipeedika Nibin Joy · 2025 · Journal of Molecular Structure
  12. Kinetic modeling of nucleated polymerization of amyloid beta and anti-amyloidogenic activity of bromocriptine in Alzheimer's disease
    Abdul Majid, Sanjeev Garg · 2025 · Process Safety and Environmental Protection
  13. Learning patient-specific spatial biomarker dynamics via operator learning for Alzheimer’s disease progression
    Jindong Wang, Yutong Mao, Xiao Liu, Wenrui Hao, Alzheimer’s Disease Neuroimaging Initiative · 2026 · npj Systems Biology and Applications
  14. Novel Treatment Options Through Light-Based Neurostimulation
    Maibritt Horning, Nikolas Johansen Aasheim, Marcus Carstensen · 2025 · Springer eBooks
  15. Protein misfolding and neurodegeneration: Mechanisms, implications, and therapeutic strategies
    Asma Shah, Tharini Karthikeyan, Sheema Hashem, Rakesh Kumar, Ajaz Ahmad Bhat, Muzafar Ahmad Macha · 2025 · Advances in protein chemistry and structural biology
  16. Synthetic-to-real attentive deep learning for Alzheimer’s assessment: A domain-agnostic framework for ROCF scoring
    Kassem Anis Bouali, Elena Šikudová · 2025 · Journal of Biomedical Informatics
  17. Nutraceutical interventions for neuroprotection: a comprehensive review
    Nabanita Ghosh, Jyotirmoy Ghosh, Sumit Ghosh, Krishnendu Sinha, Parames Chandra Sil · 2025 · Biochemical Pharmacology
  18. Treatment options for Alzheimer’s Disease: An overview of the amyloid, tau, and alternate hypotheses
    Kaan Eroltu · 2023 · Journal of High School Science
  19. Therapeutic Efficacy of Mesenchymal Stem Cells (MSCs) on Alzheimer’s Disease: Review of Clinical Results
    Ae-Lee Kim, Woon Kyu Lee, Soonjo Kwon, I. B. Han, Byung Hyune Choi · 2026 · Tissue Engineering and Regenerative Medicine
  20. Oolonghomobisflavan B Ameliorates Scopolamine-Induced Cognitive Impairment via BDNF-CREB Signaling and Antioxidant Mechanisms in Mice
    Hae-Jin Park, Jaehoon Bae · 2025 · Natural Product Sciences
  21. Zinc‐Based Nanocomposites for Alzheimer's Therapy: Restoring Metal Homeostasis and Inhibiting Neurotoxic Protein Aggregation
    Suman Yadav, Sarvesh Kumar Pandey, Shikha Awasthi · 2026 · Advanced Therapeutics
  22. Beyond the streetlight: a TREAT‐AD perspective on where to find new Alzheimer's targets
    Gregory A. Cary, Jesse C. Wiley, Gregory W. Carter, Allan I. Levey · 2026 · Alzheimer s & Dementia
  23. From Tradition to Biochemical Innovation: Phytobioactive Compounds in Modern Neuropharmacology
    Sumeet Dwivedi, Prerna Chaturvedi · 2026 · International Journal of Pharmacology
  24. Tai Chi and Qigong to Enhance Cognitive Function in Community-Dwelling Older Adults: Evidence from a Systematic Review and Meta-Analysis
    Yuelin Li, Thao Thi‐Thu Doan, Ruoran Zhao, Youmin Cho, Xing Fan, Zeyu Zhang, Tianxue Hou, Rhayun Song · 2026 · Journal of Applied Gerontology
  25. Integrated computational-based design of putative dual TrkA/TrkB agonists for Alzheimer’s disease: pharmacophore modelling, docking, MM/GBSA, DFT and dynamics studies
    A. Vignesh Pandi, Vishnu Kumar Malakar, Jeyaram Bharathi Jeyabalan, Megha Sanjai, Krishna Sambhajirao Shevate, Kalirajan Rajagopal, B R Jaidev Kumar, Antony Justin · 2026 · Frontiers in Bioinformatics
  26. 6PPD-quinone exposure and Alzheimer’s disease: insights from integrative network pharmacology, transcriptomics, machine learning, and molecular docking
    Chun Zhang, J Zhang · 2026 · Open Medicine
  27. Efficacy Measures Used in Alzheimer Disease Clinical Trials Between 2015 and 2025
    Can Li, Mengyuan Fu, Karina Berg, Joshua David Wallach, Kexin Ling, Ran Wei, Luwen Shi, Joseph S. Ross, Xiaodong Guan · 2026 · Neurology
  28. Can a Digital Therapy Using Sound and Light Reset the Balance of Alzheimer’s Disease?
    Julia N. Wood, Carson Will · 2022 · Science Insights
  29. Toward the right treatment at the right time: Modeling the trajectory of cognitive decline to identify the earliest age of change in people with Alzheimer's disease
    R. Asaad Baksh, André Strydom, Ben Carter, Isabelle Carrière, Karen A. Ritchie · 2024 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  30. Pooling Alzheimer's disease clinical trial data to develop personalized medicine approaches is easier said than done: A proof‐of‐principle study and call to action
    Mark A. Dubbelman, Eleonora M. Vromen, Betty Marije Tijms, Johannes Hans Berkhof, Lois Ottenhoff, Everard G.B. Vijverberg, Niels D. Prins, Wiesje M. van der Flier, Sietske A.M. Sikkes · 2024 · Alzheimer s & Dementia Translational Research & Clinical Interventions
  31. Synthesis, Characterization, and Biological Evaluation of N-Methyl Derivatives of Norbelladine
    S. Mahsa Hashemian, Natacha Mérindol, Alexis Paquin, Amita Singh, Lionel Berthoux, Benoit Daoust, Isabel Desgagné‐Penix · 2024 · Molecules
  32. The AβA2V paradigm: From molecular insights to therapeutic strategies in Alzheimer’s disease and primary tauopathies
    Luisa Diomede, Andrea Conz, Michele Mosconi, Tatiana Stoilova, Matteo Paloni, Matteo Salvalaglio, Alfredo Cagnotto, Laura Colombo, Marcella Catania, Giuseppe Di Fede et al. · 2024 · Pharmacological Research
  33. Topological influence of immediate-early genes in brain genetic networks and their link to Alzheimer's disease
    Margarita Zachariou, Eleni M. Loizidou, George M. Spyrou · 2025 · Computers in Biology and Medicine
  34. Down syndrome: a model for chromosome abnormalities
    Cassia Overk, William Cary Mobley · 2022 · Elsevier eBooks
  35. Aducanumab and lecanemab – two novel antibodies against pathologic species of amyloid beta in the treatment of Alzheimer’s disease
    Jakub Wojcieszak · 2023 · Farmacja Polska
  36. A unified in vitro to in vivo fluorescence lifetime screening platform yields amyloid β aggregation inhibitors
    Súil Collins, Liisa van Vliet, Fabrice Gielen, M. Janecek, Sara Wagner-Valladolid, Chetan Poudel, Giuliana Fusco, Alfonso De Simone, Claire Michel, Clemens F. Kaminski et al. · 2022 · Research Square
  37. Potential utility of plasma p-tau and NfL as surrogate biomarkers for preventive clinical trials
    Pâmela C.L. Ferreira, João Pedro Ferrari‐Souza, Cécile Tissot, Bruna Bellaver, Douglas Teixeira Leffa, Firoza Zubeida Lussier, Guilherme Povala, Joseph Therriault, Andréa Lessa Benedet, Nicholas James Ashton et al. · 2022 · medRxiv
  38. Navigating the future of Alzheimer's care in Ireland - A service model for disease-modifying therapies in small and medium-sized healthcare systems
    Iracema Leroi, Helena Dolphin, Rachel Dinh, Tony Foley, Seán Kennelly, Irina Kinchin, Rónán Ó’Caoimh, Seán O’Dowd, Laura O’Philbin, Susan O’Reilly et al. · 2023 · Research Square
  39. Overcoming the Challenges of Multi‐Target‐Directed Ligands for Alzheimer's Disease
    Elisa Uliassi, Anna Pasieka, Eleonora Diamanti, María Laura Bolognesi · 2024 · Wiley eBooks
  40. Uncovering the invisible giant: Amyloid ß plaques and their proposed association with waste removal in Alzheimer-affected human hippocampus
    Ruth Fabian‐Fine, Abigail G. Roman, Melanie J. Winters, Kyleena J. Lathram, Carly H. Bennett, Luwago K. Kipingi, Sondre M. Brännare-Gran, Abigail E Whitley, Chloe M. Paul, Lydia M. Altman et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  41. Naturally Occurring Antibodies Against Bim Are Decreased in Alzheimer’s Disease and Attenuate Ad-type Pathologies in a Mouse Model
    Jie-Ming Jian, Dong‐Yu Fan, Ding‐Yuan Tian, Yuan Cheng, Pu‐Yang Sun, Gui‐Hua Zeng, Chen-Yang He, Ye‐Ran Wang, Jie Zhu, Xiu‐Qing Yao et al. · 2021 · Research Square
  42. Combining Low-Dose Radiation Therapy and Magnetic Resonance Guided Focused Ultrasound to Reduce Amyloid-β Deposition in Alzheimer’s Disease
    Paolo Farace, Stefano Tamburin · 2021 · Journal of Alzheimer s Disease
  43. Busca por alcaloides presentes em Caliphuria subedentata como potenciais candidatos a fármacos para a Doença de Alzheimer
    Rauni Borges Marques · 2021 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  44. An online diagnosis for mild behavioral impairment diagnosis: a tool for low and middle-income countries?
    Tomás Leon · 2022 · International Psychogeriatrics
  45. New therapeutic opportunities for Alzheimer disease
    Jae‐Won Jang · 2022 · Journal of Geriatric Neurology
  46. Medikamentöse Therapie der Demenz
    Mareike Kirsch, Christine A. F. Von Arnim · 2022 · DMW - Deutsche Medizinische Wochenschrift
  47. Innovative Therapeutic Development Programme for the Treatment of Early Alzheimer's Disease: Lecanemab (BAN2401)
    Jeffrey L. Cummings · 2021 · touchREVIEWS in Neurology
  48. Editorial: Degenerative and cognitive diseases
    Luca Giliberto · 2022 · Current Opinion in Neurology
  49. INVESTIGATING TOLFENAMIC ACID AND ITS ANALOGS AS POTENTIAL ALZHEIMER’S DISEASE THERAPEUTICS
    Jaunetta Hill · 2021
  50. Alzheimer-Erkrankung – welche Substanzen befinden sich derzeit in Phase-III-Studien?
    Klaus Häger · 2022 · Der Nervenarzt
  51. Early age changes in mRNA expression related to NAD-dependent enzymes and mitochondrial proteins in the brain cortex of an Alzheimer’s disease mouse model
    Sylwia Żulińska, Iga Wieczorek, PL Wencel, Robert Piotr Strosznajder, GY Sun, Joanna Benigna Strosznajder · 2022 · Research Square
  52. Executive Summary of the 2021 International Conference of Korean Dementia Association: A Report From the Academic Committee of the Korean Dementia Association
    Kee Hyung Park, Jae‐Won Jang, Jeewon Suh, SangHak Yi, Jae‐sung Bae, Jae‐Sung Lim, Hyon Lee, Juhee Chin, Young Ho Park, Yun Jeong Hong et al. · 2022 · Dementia and Neurocognitive Disorders
  53. Towards 2022: What are prevention and risk reduction in Alzheimer’s disease?
    Ricardo Allegri · 2021 · Journal of Applied Cognitive Neuroscience
  54. Alzheimer’s Disease: Effects on brain circuits and synapses
    Toh Hean Ch’ng, George J Augustine · 2022 · Seminars in Cell and Developmental Biology
  55. Therapeutic and immunomodulatory functions of the translocator protein in Alzheimer's disease
    Lauren Hermes Fairley · 2022
  56. Screening of dementia with the IQCODE: can it be shortened?
    Teake P. Ettema · 2022 · International Psychogeriatrics
  57. Dementia’s preventative futures: researcher perspectives on prospective developments in the UK
    Miriam Fahey, Anthea Tinker, James Rupert Fletcher · 2023 · Working with Older People
  58. Experimental Medicine Approaches in Early-Phase CNS Drug Development
    Brett A. English, Larry Ereshefsky · 2023 · Advances in neurobiology
  59. Tratamiento del deterioro cognitivo
    Guillermo García‐Ribas, A. Sáez Marín, P. Lorenzo Barreto · 2023 · Medicine - Programa de Formación Médica Continuada Acreditado
  60. Effect of sodium channels in Alzheimer’s disease
    Mingqiao Li · 2023 · Highlights in Science Engineering and Technology
  61. Modification Strategies of Anti-Transferrin Receptor Antibody across the Blood-Brain Barrier
    成 瞿 · 2023 · Pharmacy Information
  62. Changes in transcription of genes encoding NAD-dependent enzymes and mitochondrial proteins in Alzheimer’s disease animal model. Indication of early targets in neuroprotection
    Sylwia Żulińska, PL Wencel, Iga Wieczorek, Robert Piotr Strosznajder, Joanna Benigna Strosznajder · 2023 · Research Square
  63. Research Progress of Stem Cell Exosomes in Alzheimer’s Disease
    良康 古 · 2023 · Bioprocess
  64. Potential Antioxidative Effects of Folic Acid and Betaine Combination Against to Amyloid beta (1-42) and Homocysteine-induced Oxidative Stress in Synaptosomes
    Mete Özkoç, Betül Can, Ayşegül Oğlakçı İlhan, İbrahim Söğüt, Zeki Serdar Ataızı, Turan Kandemir, Dilek Burukoğlu Dönmez, Güngör Kanbak · 2023 · Research Square
  65. Transcriptomic signatures of Aβ- and tau-induced neuronal dysfunction reveal inflammatory processes at the core of Alzheimer’s disease pathophysiology
    Lazaro M. Sanchez-Rodriguez, Ahmed Faraz Khan, Quadri Adewale, Gleb Bezgin, Joseph Therriault, Jaime Fernández Arias, Stijn Servaes, Nesrine Rahmouni, Cécile Tissot, Jenna Stevenson et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  66. Epigenetics and cognitive disorders—translational aspects
    Fabio Coppedè · 2024 · Elsevier eBooks
  67. Herbal Medicines for Management of Alzheimer’s Disease
    Jai Malik, Subhash Chandra Mandal, Sunayna Choudhary, Shweta Parihar, Mohamed Rahamathulla · 2023 · Springer eBooks
  68. Time Factor Hypothesis: Towards Identifying Onset of Alzheimer’s Disease in Younger Adults
    Oriehi Edisemi Destiny Anyaiwe, Chukwuemeka Sunday Konwe, Zahraddeen Gwarzo · 2023 · Series of Clinical and Medical Case Reports and Reviews
  69. Psychopharmacology in late life: Key challenges and opportunities
    Shubham Ramdas Mule, Vinayak Pawar, Muktika Tekade, Nupur Vasdev, Tanisha Gupta, Amrita Singh, Satyajit Dey Sarker, Rakesh Kumar Tekade · 2024 · Elsevier eBooks
  70. Effect of Melilotus Extract and Exercise on Oxidative Stress and Neuroinflammation in an Alzheimer's Mouse Model
    Farah Nameni, Ghazal Akbari, Vahid Hadavand, Hasan Entezari, Shabnam Molaii, Naficeh Ghadami · 2024 · Jentashapir Journal of Cellular and Molecular Biology
  71. The effects of musicality on brain network topology in the context of Alzheimer’s disease and memory decline
    Anna Maria Matziorinis, Alexander Leemans, Stavros Skouras, Birthe Kristin Flo, Tobias Bashevkin, Stefan Koelsch · 2024 · Imaging Neuroscience
  72. SIMULATION OF ACETYLCHOLINESTERASE INHIBITORS’ IMPACTS ON EMERGING AND PROGRESSING ALZHEIMER’S DISEASE BY CELLULAR AUTOMATA MODELING
    NILOOFAR JAFARI, Faegheh Golabi, Abbas Ebrahimi Kalan, Yashar Sarbaz · 2024 · Journal of Biological Systems
  73. Differential Biological Effects of a Single Natural Product Depending on the Site of Action
    2024 · Royal Society of Chemistry eBooks
  74. Unraveling Alzheimer's disease heterogeneity:
    Eleonora M. Vromen · 2024
  75. Neuroprotective effects of Carpinus tschonoskii leave extract against glutamate-induced oxidative stress and apoptosis in HT22 mouse hippocampal cells
    Ji-Woon Hwang, Song-I Han, Jae Hoon Kim · 2025 · Journal of Applied Biological Chemistry
  76. Novel Approaches for Treating Alzheimer’s Disease and Other Dementias
    M. Catarina Silva, David C. Butler, Sally Temple, Stephen J. Haggarty · 2025
  77. Investigating Neurodegenerative Disorders
    Bhaskar Kishore, Tharaka Srinatha Dunuwila · 2025 · IGI Global eBooks
  78. Discovering potent GSK3β inhibitors in Rosmarinus officinalis L. for Alzheimer’s disease using homology modeling, molecular docking, MD simulation
    Amisha Bisht, Anita Nayal, Disha Tewari · 2025 · Network Modeling Analysis in Health Informatics and Bioinformatics
  79. Early Alzheimer’s disease: Clinical overview
    James Selwood, Elizabeth Jane Coulthard · 2025 · Elsevier eBooks
  80. Clinical trials
    Sarah Gregory, Stina Saunders, Craig William Ritchie · 2025 · Elsevier eBooks
  81. Mechanism of synergistic enhancement of α-secretase (ADAM10) activity by EGCG and FA
    Yvning Guan, Wen Xu, Hongqi Ai · 2025 · ChemPhysMater
  82. The effects of weight training and Aklil-ol-Malek on histopathology and C-reactive protein, nuclear factor erythroid-derived 2-like 2 beta-site Amyloid Precursor protein cleaving enzyme1 genes expression in Alzheimer's disease model rats
    Farah Nameni, Mohammad Reza Amir Khan Dehkordi · 2025 · Journal of Neurorestoratology
  83. Effects of Transcranial Focused Magnetoacoustic Electrical Stimulation on the EEG Signal of Alzheimer's Disease Rats
    Ruolan Yang, Manxi Xu, Jixin Luan et al. · 2025 · IEEE Journal of Electromagnetics RF and Microwaves in Medicine and Biology
  84. Targeted therapy in older adults with Alzheimer disease: a review
    Polina A. Bulina, Polina A. Popova, Lyubov S. Dyatchina, Maria M. Goliatina, A. Zaitseva, Anastasia A. Abramenko, Kirill P. Raevskii · 2025 · Russian Medicine
  85. Targeting Microglial Phagocytosis for Alzheimer's Disease Management: Natural, Pharmacological, Nanoparticle, and Gene Therapy Approaches
    Shalini Raghuvanshi, Avijit Mazumder, Saumya Das · 2025 · CNS & Neurological Disorders - Drug Targets
  86. Turkish marine biodiversity: chemical profile and in vitro biological activities
    Belma Konuklugil, Büllent Gözcelioğlu, Karolyna Lauterjung Lopes · 2025 · Journal of the Marine Biological Association of the United Kingdom
  87. Egzersizin Nörolojik Hastalıklarda Tedavi Edici Etkisi; Alzheimer Örneği
    Büşra Yılmaz · 2025 · Iğdır Üniversitesi Spor Bilimleri Dergisi
  88. Integrative Approach Towards Treatment of Alzheimer's and Other Dementias
    Nihad Ashraf Khan, Niti Sambyal, Tanzeelah, Punya Sachdeva, Deepali Siwan, Andleeb Rehman, Anuvab Dey, Subhrojyoti Ghosh, Atharva Anand Mahajan, Saliha Rizvi et al. · 2025 · Advances in Integrative Medicine
  89. Lab-grown mini-brains could help find treatments for Alzheimer’s and other diseases
    Étienne Aumont · 2022
  90. The global patent landscape of the drugs for treating Alzheimer’s disease from 2014–2023
    Yan Xu, Yuan Z. Gao · 2025 · BMC Neurology
  91. The Gut-Brain Axis in Neurodegenerative Disorders: Evaluating the Therapeutic Potential of Probiotics and Fecal Microbiota Transplantation
    Bhaskar Jyoti Sharma, Abu Saif Mustaque · 2025 · Research Square
  92. The Search for Answers: Causes, Risk Factors, and Current Research in Neurodegenerative Disorders
    Amita Kajrolkar · 2025 · Premier Journal of Neuroscience
  93. Analytical considerations and clinical utility of plasma phosphorylated Tau217
    Hans Frykman · 2025 · Critical Reviews in Clinical Laboratory Sciences
  94. MAPT Haplotype Variation and Alzheimer’s Disease Risk: A Narrative Review with Focus on the Jordanian Population
    Alaa A. A. Aljabali, Almuthanna K. Alkaraki, Mohammad A. Obeid · 2025 · Current Neuropharmacology
  95. The gut–brain axis in neurodegenerative disorders: Evaluating the therapeutic potential of probiotic and fecal microbiota transplantation
    Bhaskar Jyoti Sharma · 2025 · Research Square
  96. Exercise as a Therapeutic Intervention for Alzheimer’s Disease
    Dong-Joo Hwang, Joon-Yong Cho · 2025 · Advances in neurobiology
  97. The biological diagnosis of Alzheimer’s disease using blood-based biomarkers: a Canadian prospective
    Pankaj Kumar, Ali Mousavi, Hans Frykman · 2025 · Clinical Biochemistry
  98. Relationships between alcohol use and dementia: protocol for an observational study in the UK Clinical Practice Research Datalink
    Nasri Fatih, Krishnan Bhaskaran, Aden Chun Hei Kwok · 2025 · medRxiv
  99. A fully immersive gamified virtual reality assessment of functional cognition
    Zhao Liu, Daniele Soria, Sukhwinder Singh Shergill, Chee Siang Ang · 2025 · Research Square
  100. SmrutiPankh: An Automated Real-Time Assistance Device for Alzheimer’s Patients
    Janvi S. Bhoyar, Shantanu Anandrao Lohi, Umaima Syeda Fatima · 2025 · Lecture notes in networks and systems